ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,887Medicare Part D Prescriptions Filled, Including Refills

Rank: 261 out of 1802

$355K Total Retail Price of All Prescriptions

Rank: 276 out of 1802

319 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 319 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 319 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 5,692 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 261 229 1 2
SIMVASTATIN 258 219 2 1
FUROSEMIDE 237 218 3 5
LISINOPRIL 231 222 4 3
WARFARIN SODIUM 222 220 5 7
METOPROLOL TARTRATE 181 164 6 9
OMEPRAZOLE 180 144 7 4
AMLODIPINE BESYLATE 159 136 8 6
GABAPENTIN 132 93 9 16
HYDROCHLOROTHIAZIDE 127 112 10 8
LOSARTAN POTASSIUM 119 96 11 18
HYDROCODONE-ACETAMINOPHEN 111 88 S3 12 10
METFORMIN HCL 94 62 13 11
TAMSULOSIN HCL 92 88 14 28
DONEPEZIL HCL 92 91 14 26
METOPROLOL SUCCINATE 92 88 14 13
TRAMADOL HCL 92 90 14 22
PREDNISONE 89 85 18 33
CITALOPRAM HBR 88 82 19 17
BYSTOLIC 84 58 20 120
LOVASTATIN 82 80 21 25
ISOSORBIDE MONONITRATE ER 79 72 22 66
PRAVASTATIN SODIUM 79 67 22 19
ALLOPURINOL 75 63 24 24
SERTRALINE HCL 75 54 24 20
POLYETHYLENE GLYCOL 3350 73 53 26 29
FENTANYL 68 66 S2 27 43
FINASTERIDE 64 60 28 88
POTASSIUM CHLORIDE 62 62 29 15
RANITIDINE HCL 59 55 30 30
MIRTAZAPINE 59 47 30 38
LANTUS 58 37 32 47
CARBIDOPA-LEVODOPA 58 58 32 70
QUETIAPINE FUMARATE 57 53 34 54
ATORVASTATIN CALCIUM 56 49 35 14
CARVEDILOL 55 45 36 36
METHADONE HCL 53 34 S2 37 113
TORSEMIDE 52 48 38 181
SPIRONOLACTONE 52 52 38 53
CRESTOR 51 36 40 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.